Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131000 · ClinicalTrials.gov registry record · Phase 3
Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients
A Phase 3 study of Fever, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 123
- Enrollment target
- 11
- Study locations
NCT01131000: Completed Phase 3 study of Fever, sponsored by Cumberland Pharmaceuticals.
NCT01131000 is a Phase 3 study of Fever that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 123 participants, below the 593-participant average among 18 other Fever trials with a reported enrollment target (79% lower). The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01131000, a Phase 3 study of Fever, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 123 participants
- Enrollment target
- 11
- Study locations
Study Summary
The primary objective of this study is to evaluate the efficacy of intravenous ibuprofen on reducing fever at 4 hours.
Conditions Studied
Interventions
- DRUG Ibuprofen
- OTHER Normal Saline
Study Locations (11)
Tennessee
- Methodist Healthcare - University Hospital - Memphis
- Vanderbilt University Medical Center - Nashville
- Skyline Medical Center - Nashville
North Carolina
- Moses H. Cone Memorial Hospital - Greensboro
- Wake Forest University Health Sciences - Winston-Salem
Florida
- Orlando Regional Medical Center - Orlando
Missouri
- Barnes Jewish Hospital - St Louis
Texas
- Ben Taub General Hospital - Houston
New South Wales
- Newcastle Mater Misericordiae Hospital - New Lambton
South Australia
- Flinders Medical Centre - Adelaide
Other
- Mahidol University Siriraj Hospital - Bangkok
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2002-06 |
| Est. Completion | 2005-08 |
| Phase | Phase 3 |
What the finished NCT01131000 record still lists
NCT01131000 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 593-participant average among 18 other Fever trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Fever appearing as the primary indexed condition, and to 2 interventions - of which Ibuprofen is the first listed.
NCT01131000 lists 11 locations in 8 states (Tennessee, North Carolina, Florida).
Frequently Asked Questions
What is clinical trial NCT01131000 about?
NCT01131000 is a clinical study titled "Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients". The primary objective of this study is to evaluate the efficacy of intravenous ibuprofen on reducing fever at 4 hours.
What is the current status of trial NCT01131000?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 123 participants. The study started on 2002-06. Estimated completion is 2005-08.
What conditions does trial NCT01131000 study?
This clinical trial studies the following conditions: Fever.
What interventions are being tested in trial NCT01131000?
The interventions under investigation include: Ibuprofen (DRUG), Normal Saline (OTHER).
Who is sponsoring clinical trial NCT01131000?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01131000 being conducted?
This trial has 11 study locations across Florida, Missouri, North Carolina, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fever
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01131000's enrollment target sits among peer trials
123 10th of 18 higher than 9 of 18 other Fever trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fever trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients
COMPLETED · Phase 3
-
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer
COMPLETED · Phase 3
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Remote Temperature Monitoring of Patients At Risk for Developing Fever
RECRUITING · NA
-
Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department
RECRUITING · NA
-
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia